Differentiating Hemangioblastomas from Brain Metastases Using Diffusion-Weighted Imaging and Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted MR Imaging

References

1. 1.↵
   2. Louis DN,
   3. Ohgaki H,
   4. Wiestler OD, et al

   . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109 doi:10.1007/s00401-007-0243-4 pmid:17618441

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Young S,
   3. Richardson AE

   . Solid haemangioblastomas of the posterior fossa: radiological features and results of surgery. J Neurol Neurosurg Psychiatry 1987;50:155–58 doi:10.1136/jnnp.50.2.155 pmid:3494815

   Abstract/FREE Full Text
3. 3.↵
   2. Yoshida S,
   3. Takahashi H

   . Cerebellar metastases in patients with cancer. Surg Neurol 2009;71:184–87; discussion 187 doi:10.1016/j.surneu.2007.10.010 pmid:18295837

   CrossRefPubMed
4. 4.↵
   2. Kanner AA,
   3. Suh JH,
   4. Siomin VE, et al

   . Posterior fossa metastases: aggressive treatment improves survival. Stereotact Funct Neurosurg 2003;81:18–23 doi:10.1159/000075099 pmid:14742959

   CrossRefPubMed
5. 5.↵
   2. Alexandru D,
   3. Bota DA,
   4. Linskey ME

   . Epidemiology of central nervous system metastases. Prog Neurol Surg 2012;25:13–29 doi:10.1159/000331167 pmid:22236665

   CrossRefPubMed
6. 6.↵
   2. Bründl E,
   3. Schödel P,
   4. Ullrich OW, et al

   . Surgical resection of sporadic and hereditary hemangioblastoma: our 10-year experience and a literature review. Surg Neurol Int 2014;5:138 doi:10.4103/2152-7806.141469 pmid:25317353

   CrossRefPubMed
7. 7.↵
   2. Tabei Y,
   3. Miyamoto S,
   4. Suzuki I

   . Multidisciplinary approach to management of patients with brain metastases [in Japanese]. Gan To Kagaku Ryoho 2013;40:1288–94 pmid:24105053

   PubMed
8. 8.↵
   2. Le Reste PJ,
   3. Henaux PL,
   4. Morandi X, et al

   . Sporadic intracranial haemangioblastomas: surgical outcome in a single institution series. Acta Neurochir (Wien) 2013;155:1003–09; discussion 1009 doi:10.1007/s00701-013-1681-5 pmid:23558723

   CrossRefPubMed
9. 9.↵
   2. Sakamoto N,
   3. Ishikawa E,
   4. Nakai Y, et al

   . Preoperative endovascular embolization for hemangioblastoma in the posterior fossa. Neurol Med Chir (Tokyo) 2012;52:878–84 doi:10.2176/nmc.52.878 pmid:2326904

   CrossRefPubMed
10. 10.↵
    2. Schaefer PW,
    3. Grant PE,
    4. Gonzalez RG

    . Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331–45 doi:10.1148/radiology.217.2.r00nv24331 pmid:11058626

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Kang Y,
    3. Choi SH,
    4. Kim YJ, et al

    . Gliomas: histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging–correlation with tumor grade. Radiology 2011;261:882–90 doi:10.1148/radiol.11110686 pmid:21969667

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Quadery FA,
    3. Okamoto K

    . Diffusion-weighted MRI of haemangioblastomas and other cerebellar tumours. Neuroradiology 2003;45:212–19 pmid:12687303

    PubMedWeb of Science
13. 13.↵
    2. Kickingereder P,
    3. Wiestler B,
    4. Sahm F, et al

    . Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging. Radiology 2014;272:843–50 doi:10.1148/radiol.14132740 pmid:24814181

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Guzmán-De-Villoria JA,
    3. Mateos-Pérez JM,
    4. Fernández-García P, et al

    . Added value of advanced over conventional magnetic resonance imaging in grading gliomas and other primary brain tumors. Cancer Imaging 2014;14:35 doi:10.1186/s40644-014-0035-8 pmid:25608821

    CrossRefPubMed
15. 15.↵
    2. Ho CY,
    3. Cardinal JS,
    4. Kamer AP, et al

    . Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors. Neuroradiology 2015;57:299–306 doi:10.1007/s00234-014-1478-0 pmid:25504266

    CrossRefPubMed
16. 16.↵
    2. Kumar VA,
    3. Knopp EA,
    4. Zagzag D

    . Magnetic resonance dynamic susceptibility-weighted contrast-enhanced perfusion imaging in the diagnosis of posterior fossa hemangioblastomas and pilocytic astrocytomas: initial results. J Comput Assist Tomogr 2010;34:825–29 doi:10.1097/RCT.0b013e3181ef77e2 pmid:21084895

    CrossRefPubMed
17. 17.↵
    2. She DJ,
    3. Xing Z,
    4. Zeng Z, et al

    . Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy. Neuroradiology 2015;57:275–81 doi:10.1007/s00234-014-1475-3 pmid:25487356

    CrossRefPubMed
18. 18.↵
    2. Hakyemez B,
    3. Erdogan C,
    4. Bolca N, et al

    . Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 2006;24:817–24 doi:10.1002/jmri.20707 pmid:16958061

    CrossRefPubMed
19. 19.↵
    2. Wetzel SG,
    3. Cha S,
    4. Johnson G, et al

    . Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797–803 doi:10.1148/radiol.2243011014 pmid:12202717

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Cuccurullo L,
    3. Prudente ME,
    4. Maffia S, et al

    . An ultrastructural study of the histogenesis of haemangioblastoma. Pathologica 2009;101:1–5 pmid:19771763

    PubMed
21. 21.↵
    2. Guo AC,
    3. Cummings TJ,
    4. Dash RC, et al

    . Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224:177–83 doi:10.1148/radiol.2241010637 pmid:12091680

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Barajas RF Jr.,
    3. Rubenstein JL,
    4. Chang JS, et al

    . Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 2010;31:60–66 doi:10.3174/ajnr.A1750 pmid:19729544

    Abstract/FREE Full Text
23. 23.↵
    2. Hayashida Y,
    3. Hirai T,
    4. Morishita S, et al

    . Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 2006;27:1419–25 pmid:16908550

    Abstract/FREE Full Text
24. 24.↵
    2. Jain R,
    3. Gutierrez J,
    4. Narang J, et al

    . In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas. AJNR Am J Neuroradiol 2011;32:388–94 doi:10.3174/ajnr.A2280 pmid:21071537

    Abstract/FREE Full Text
25. 25.↵
    2. Maia AC Jr.,
    3. Malheiros SM,
    4. da Rocha AJ, et al

    . MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 2005;26:777–83 pmid:15814920

    Abstract/FREE Full Text
26. 26.↵
    2. Bing F,
    3. Kremer S,
    4. Lamalle L, et al

    . Value of perfusion MRI in the study of pilocytic astrocytoma and hemangioblastoma: preliminary findings [in French]. J Neuroradiol 2009;36:82–87 doi:10.1016/j.neurad.2008.09.002 pmid:18930545

    CrossRefPubMed
27. 27.↵
    2. Hussein MR

    . Central nervous system capillary haemangioblastoma: the pathologist's viewpoint. Int J Exp Pathol 2007;88:311–24 doi:10.1111/j.1365-2613.2007.00535.x pmid:17877533

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Tsougos I,
    3. Svolos P,
    4. Kousi E, et al

    . Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T. Cancer Imaging 2012;12:423–36 doi:10.1102/1470-7330.2012.0038 pmid:23108208

    CrossRefPubMed
29. 29.↵
    2. Gaudino S,
    3. Di Lella GM,
    4. Russo R, et al

    . Magnetic resonance imaging of solitary brain metastases: main findings of nonmorphological sequences. Radiol Med 2012;117:1225–41 doi:10.1007/s11547-012-0846-2 pmid:22744350

    CrossRefPubMed
30. 30.↵
    2. Biondi A,
    3. Ricciardi GK,
    4. Faillot T, et al

    . Hemangioblastomas of the lower spinal region: report of four cases with preoperative embolization and review of the literature. AJNR Am J Neuroradiol 2005;26:936–45 pmid:15814949

    Abstract/FREE Full Text
31. 31.↵
    2. Chu BC,
    3. Terae S,
    4. Hida K, et al

    . MR findings in spinal hemangioblastoma: correlation with symptoms and with angiographic and surgical findings. AJNR Am J Neuroradiol 2001;22:206–17 pmid:11158911

    Abstract/FREE Full Text
32. 32.↵
    2. Horská A,
    3. Barker PB

    . Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am 2010;20:293–310 doi:10.1016/j.nic.2010.04.003 pmid:20708548

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Brandão LA,
    3. Castillo M

    . Adult brain tumors: clinical applications of magnetic resonance spectroscopy. Neuroimaging Clin N Am 2013;23:527–55 doi:10.1016/j.nic.2013.03.002 pmid:23928203

    CrossRefPubMed